Cite

HARVARD Citation

    Wong, S. et al. (n.d.). 353 HIF-2 alpha targeting with a novel RNAi delivery platform as therapy for renal cell carcinoma. European journal of cancer. pp. S71-S72. [Online]. 
  
Back to record